Financials Procter & Gamble Company

Equities

PG

US7427181091

Personal Products

Market Closed - Nyse 04:03:09 2023-11-30 pm EST Intraday chart for Procter & Gamble Company 5-day change 1st Jan Change
153.52 USD +1.58% +1.66% +1.29%

Valuation

Fiscal Period : Juni 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 275 038 296 013 330 340 344 995 357 647 356 196 - -
Enterprise Value (EV) 1 300 891 314 552 352 040 369 274 384 008 383 091 381 700 379 411
P/E ratio 76,7x 24,1x 24,5x 24,7x 25,7x 23,5x 21,8x 20,2x
Yield 2,64% 2,53% 2,40% 2,45% 2,43% 2,52% 2,63% 2,75%
Capitalization / Revenue 4,06x 4,17x 4,34x 4,30x 4,36x 4,19x 4,04x 3,88x
EV / Revenue 4,45x 4,43x 4,62x 4,61x 4,68x 4,51x 4,33x 4,13x
EV / EBITDA 17,6x 16,4x 17,0x 17,9x 18,4x 16,7x 15,7x 14,6x
EV / FCF 25,3x 22,0x 22,6x 27,2x 27,9x 24,9x 23,4x 22,0x
FCF Yield 3,95% 4,56% 4,43% 3,67% 3,59% 4,02% 4,27% 4,56%
Price to Book 5,76x 6,32x 7,03x 7,35x - 7,56x 7,10x 6,63x
Nbr of stocks (in thousands) 2 508 330 2 475 643 2 448 233 2 399 297 2 356 969 2 356 886 - -
Reference price 2 110 120 135 144 152 151 151 151
Announcement Date 30/07/19 30/07/20 30/07/21 29/07/22 28/07/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period : Juni 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 67 684 70 950 76 118 80 187 82 006 85 011 88 192 91 889
EBITDA 1 17 060 19 156 20 721 20 620 20 848 22 947 24 311 26 020
EBIT 1 14 236 16 143 17 986 17 813 18 134 20 113 21 328 22 816
Operating Margin 21,0% 22,8% 23,6% 22,2% 22,1% 23,7% 24,2% 24,8%
Earnings before Tax (EBT) 1 6 069 15 834 17 615 17 995 18 353 20 070 21 207 22 666
Net income 1 3 897 13 027 14 306 14 742 14 653 15 807 16 790 17 933
Net margin 5,76% 18,4% 18,8% 18,4% 17,9% 18,6% 19,0% 19,5%
EPS 2 1,43 4,96 5,50 5,81 5,90 6,43 6,92 7,48
Free Cash Flow 1 11 895 14 330 15 584 13 567 13 786 15 403 16 306 17 285
FCF margin 17,6% 20,2% 20,5% 16,9% 16,8% 18,1% 18,5% 18,8%
FCF Conversion (EBITDA) 69,7% 74,8% 75,2% 65,8% 66,1% 67,1% 67,1% 66,4%
FCF Conversion (Net income) 305% 110% 109% 92,0% 94,1% 97,4% 97,1% 96,4%
Dividend per Share 2 2,90 3,03 3,24 3,52 3,68 3,80 3,98 4,16
Announcement Date 30.07.19 30.07.20 30.07.21 29.07.22 28.07.23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period : Juni 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 18 946 20 338 20 953 19 381 19 515 20 612 20 773 20 068 20 553 21 871 21 687 20 558 20 960 22 599 22 541
EBITDA 1 4 250 5 734 5 852 4 714 4 320 5 602 5 438 4 940 4 868 6 469 6 100 5 331 5 196 6 850 6 550
EBIT 1 3 540 5 023 5 168 4 024 3 598 4 939 4 785 4 248 4 162 5 767 5 368 4 594 4 454 6 021 5 723
Operating Margin 18,7% 24,7% 24,7% 20,8% 18,4% 24,0% 23,0% 21,2% 20,3% 26,4% 24,8% 22,3% 21,3% 26,6% 25,4%
Earnings before Tax (EBT) 1 3 564 5 035 5 239 4 071 3 650 4 997 4 835 4 288 4 233 5 802 5 350 4 594 4 485 5 930 5 619
Net income 1 2 906 4 112 4 223 3 355 3 052 3 939 3 933 3 397 3 384 4 521 4 210 3 611 3 544 4 713 4 470
Net margin 15,3% 20,2% 20,2% 17,3% 15,6% 19,1% 18,9% 16,9% 16,5% 20,7% 19,4% 17,6% 16,9% 20,9% 19,8%
EPS 2 1,13 1,61 1,66 1,33 1,21 1,57 1,59 1,37 1,37 1,83 1,71 1,47 1,44 1,96 1,85
Dividend per Share 2 0,87 0,87 0,87 0,87 0,91 0,91 0,91 0,91 0,94 0,94 0,94 0,94 0,97 0,99 0,99
Announcement Date 30.07.21 19.10.21 19.01.22 20.04.22 29.07.22 19.10.22 19.01.23 21.04.23 28.07.23 18.10.23 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period : Juni 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 25 853 18 539 21 700 24 279 26 361 26 895 25 503 23 215
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1,52x 0,97x 1,05x 1,18x 1,26x 1,17x 1,05x 0,89x
Free Cash Flow 1 11 895 14 330 15 584 13 567 13 786 15 403 16 306 17 285
ROE (net income / shareholders' equity) 23,6% 27,6% 30,6% 31,5% 31,2% 33,0% 35,0% 35,1%
Shareholders' equity 1 16 481 47 229 46 766 46 754 46 959 47 947 48 033 51 033
ROA (Net income/ Total Assets) 10,2% 11,0% 11,9% 12,5% 12,3% 12,8% 13,1% 13,9%
Assets 1 38 292 117 898 120 004 118 257 119 019 123 686 128 590 128 893
Book Value Per Share 2 19,0 18,9 19,2 19,6 - 20,0 21,3 22,8
Cash Flow per Share 2 6,00 6,63 7,06 6,59 6,78 7,92 8,40 9,06
Capex 1 3 347 3 073 2 787 3 156 3 062 3 930 4 015 4 114
Capex / Sales 4,95% 4,33% 3,66% 3,94% 3,73% 4,62% 4,55% 4,48%
Announcement Date 30.07.19 30.07.20 30.07.21 29.07.22 28.07.23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating :
Investor Rating :
ESG Refinitiv :
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
153.52USD
Average target price
164.31USD
Spread / Average Target
+7.03%
Consensus
1st Jan change Capi.
+1.29% 356 B $
-9.86% 119 B $
-0.51% 71 166 M $
-0.03% 64 124 M $
-48.53% 44 946 M $
-.--% 38 453 M $
+20.06% 32 127 M $
-3.95% 17 838 M $
+15.35% 12 287 M $
-4.17% 11 368 M $
Other Personal Products
  1. Stock
  2. Equities
  3. Stock Procter & Gamble Company - Nyse
  4. Financials Procter & Gamble Company
The best tools reserved for subscribers to boost the performance of your investments!
Optimize my profits
fermer